Medical Research News

RSS

The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

A recent article assessed the potency of tixagevimab/cilgavimab in averting SARS-CoV-2 infection in vaccinated immunocompromised people.

31 May 2022

Researchers show how electrical stimulation of the vagus nerve in inflammation promotes healing

The nervous system is known to communicate with the immune system and regulate inflammation in the body. Researchers at Karolinska Institutet in Sweden now show how electrical activation of a specific nerve can promote healing in acute inflammation.

31 May 2022

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

Researchers evaluated the impact of CMV seropositivity on humoral and cellular immune responses generated after double and/or triple mRNA vaccination against SARS-CoV-2 among the elderly.

31 May 2022

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

A recent study evaluated the protection conferred by mRNA vaccines and prior infection against the SARS-CoV-2 Omicron variant.

31 May 2022

Can COVID-19 pass from mothers to newborns?

Researchers from the Hospital General Universitario Gregorio Marañón have been investigating the spread of the disease from pregnant women to newborns.

31 May 2022

New discovery could pave the way for more effective cancer immunotherapy

A type of white blood cell previously known only as a helper in the immune system appears also to be the instigator of the body's defenses against cancerous tumors.

31 May 2022

The pineapple-derived jacalin-related lectin as a potential anti-SARS-CoV-2 agent

Scientists demonstrated that the pineapple-derived jacalin-related lectin (AcmJRL/AnLec) could be an anti-SARS-CoV-2 agent.

31 May 2022

The immunogenicity and safety of the adjuvanted recombinant protein vaccine Sanofi/GSK-D614 or -B.1.351 administered as a heterologous booster dose

Researchers assessed the safety and immunogenicity of SARS-CoV-2 booster vaccines.

31 May 2022

Effectiveness of copper nanoparticle-based spray coating against SARS-CoV-2

Researchers demonstrate how copper NPs can potentially be incorporated into filters, PPE, facemasks, and clothing to effectively inactivate SARS-CoV-2.

31 May 2022

HIV research enables knowledge transfer for improved COVID-19 response

Global virology and immunology networks that were originally developed for HIV vaccine research were rapidly adapted to study COVID-19.

31 May 2022

SARS-CoV-2 evolutionary trends provide insights into its adaptive process to human hosts

The loss of genome heterogeneity in CoVs leads to high viral fitness variants that adapt to the human host.

31 May 2022

COVID-19 lockdown restrictions impacted hospital admission rates throughout U.K.

Researchers quantify the impact that COVID-19 lockdowns had on healthcare services throughout the United Kingdom

31 May 2022

Unsweetened and sugar-sweetened coffee drinkers may have lower risk of death

A cohort study has found that compared to non-coffee drinkers, adults who drank moderate amounts (1.5 to 3.5 cups per day) of unsweetened coffee or coffee sweetened with sugar were less likely to die during a 7-year follow up period.

31 May 2022

New compounds for cancer immunotherapy via STING-mediated immune activation

Innovations in cancer immunotherapy have achieved clinical success by considerably increasing the survival rate of patients undergoing cancer treatment.

31 May 2022

Vitamin D therapy may be a useful addition to the treatment of ovarian cancer, study suggests

Ovarian cancer has one of the highest death rates of all cancers. One reason for this is that cancer turns the body's defenses against itself. However, new research from Nagoya University published in Matrix Biology suggests that vitamin D can effectively prevent one of the key pathways used by this cancer.

30 May 2022

Study reveals COVID-19's collateral damage on global cardiovascular services

A major study has revealed the "global collateral damage" caused by the disruption to cardiac services from the COVID-19 pandemic.

30 May 2022

New project investigates better ways to care for the psychological wellbeing of mothers

New mums can access free online self-care resources to help them cope with the challenges of motherhood, as part of an ongoing research trial by The University of Queensland.

30 May 2022

Discovery explains why patients with severe asthma are unresponsive to treatment

Patients with the most severe form of asthma produce special substances in their airways when taking medicine during an asthma attack that block the treatment from working, according to a study where Rutgers scientists collaborated with researchers at Genentech, a member of the Roche Group.

30 May 2022

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Millions of consumers and patients around the world will be heartened by the results of the latest study on cannabis and driving.

30 May 2022

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

The internationally renowned pharmaceutical scientist Professor Hans Lennernäs of Uppsala University has been given a Humboldt Research Award worth EUR 60,000 by the Alexander von Humboldt Foundation.

30 May 2022

Medical Research News

The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

Researchers show how electrical stimulation of the vagus nerve in inflammation promotes healing

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

Can COVID-19 pass from mothers to newborns?

New discovery could pave the way for more effective cancer immunotherapy

The pineapple-derived jacalin-related lectin as a potential anti-SARS-CoV-2 agent

The immunogenicity and safety of the adjuvanted recombinant protein vaccine Sanofi/GSK-D614 or -B.1.351 administered as a heterologous booster dose

Effectiveness of copper nanoparticle-based spray coating against SARS-CoV-2

HIV research enables knowledge transfer for improved COVID-19 response

SARS-CoV-2 evolutionary trends provide insights into its adaptive process to human hosts

COVID-19 lockdown restrictions impacted hospital admission rates throughout U.K.

Unsweetened and sugar-sweetened coffee drinkers may have lower risk of death

New compounds for cancer immunotherapy via STING-mediated immune activation

Vitamin D therapy may be a useful addition to the treatment of ovarian cancer, study suggests

Study reveals COVID-19's collateral damage on global cardiovascular services

New project investigates better ways to care for the psychological wellbeing of mothers

Discovery explains why patients with severe asthma are unresponsive to treatment

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News